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Background: To understand the prevalence and characteristics of human cytomegalovirus (HCMV) infection in
children in the Weifang area, and to provide information for its prevention and treatment.
Methods: A comprehensive survey was performed from 2009 to 2012 in 7582 children from birth to 6 years of age
hospitalized in the Maternity and Child Health Hospital of Weifang. ELISA HCMV serology results and survey data
were analyzed by age group and socio-economic level. The infection rates were based on IgG and IgM serology.
Results and conclusions: The overall infection rate from IgG and IgM in the Weifang area from 2009 to 2012 was
42.5% (3496/7582), among which 34.2% were HCMV-IgG positive, suggesting past infection. Overall, the probability
of active HCMV infection showed no gender difference in any age group (P >0.05). Recent infections centered on
the first 6 months of life, presumably due to breastfeeding. Among the 654 children hospitalized for active HCMV
infection, 379 (57.9%) were from rural areas and 275 (42.1%) from urban areas, showing that active infection in the
countryside was higher than that in the city (χ2 = 32.65, p <0.01).
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Human cytomegalovirus (HCMV) belongs to the beta
herpes family and it is one of the most common causes
of human infectious diseases. Most people acquire the
infection in childhood or youth. HCMV infection often
affects multiple systems; while liver involvement is more
common [1], it can also cause problems in the respira-
tory, nervous, and vascular system, and lead to fetal mal-
formations [2-5].
Sero-epidemiological studies show that in developed
countries such as the UK and the USA, ~50% of adults
show evidence of past HCMV infection [6]. In developing
countries, HCMV infection in older children and adults
can be as high as 90-100%. Epidemiological studies play
an increasingly prominent role in its prevention and prog-
nostic evaluation. Therapy can only effectively suppress
viral replication, but cannot completely eliminate the* Correspondence: wangbinqd@hotmail.com
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reproduction in any medium, provided the orvirus. So far, no clinically safe and effective HCMV vaccine
is available. Here, we carried out a survey over the past
three years in Weifang, a city in eastern China, to provide
a database for HCMV infection in children so as to better




Among the 7852 children, the overall rate of infection was
42.5% (overall % = IgM+ %+ IgG+ IgM+ %+ IgG+ %). The
results are detailed in Table 1.
Age distribution
The total infection rate peaked in the 4–6 month age group.
The data analysis showed that recent infections centered on
babies aged 29 days to 6 months (Table 2, Figure 1).
Regional distribution of active HCMV infection
In 7852 children, 654 (8.3%) were serum IgM-positive,
indicating active HCMV infection. Among the 654 chil-
dren hospitalized with active infection, 379 (57.9%) were. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Serological results from 7852 children with
HCMV in Weifang from 2009 to 2012
HCMV-IgG HCMV-IgM Number of cases (%)
- - 4516 (57.5)
- + 311 (3.9)
+ + 343 (4.4)
+ - 2842 (34.2)
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The difference was significant (χ2 = 32.65, p <0.01).Discussion
HCMV seroepidemiology is determined by factors such
as age and socio-economic/public health conditions, and
varies from 40% to 100% seropositive adults in different
geographic and socio-economic populations. According
to the epidemiological data obtained in 2009, the HCMV
seroprevalence in Ji'nan, China, is 33.49% in people <20
years old while it is 48.3% in those >20 years old [7].
Our seroepidemiological survey showed that the overall
infection rate of HCMV in children from 2009 to 2012
was 42.5%, higher than that in Ji'nan. Compared to other
countries, the rate was lower than in African populations
<10 years old, but higher than populations in developed
countries <15 years old. In our data, the HCMV-IgG-
positive rate was 34.2%, suggesting serological evidence
of past infection; this is a lower positivity-rate than in
developed countries. However, in infants <6 months old,
it is unclear whether this was due to vertical transmis-
sion or fetal transmission from the mother.Table 2 Distribution of serological results in different age gro
Age group IgG- IgM- (%) IgG+ alone (%) IgM+ alone (%) IgG+ I
1-14 d 938 548 8 8
(62.5) (36.5) (0.5) (0.5)
15-28 d 384 179 8 1
(67.1) (31.3) (1.4) (1.7)
29 d-3 m 982 392 221 180
(55.3) (22.1) (12.5) (10.1)
4-6 m 315 230 50 110
(44.7) (32.6) (7.1) (15.6)
7-12 m 944 868 17 35
(50.6) (46.6) (0.9) (1.9)
1-3 y 521 288 6 5
(63.6) (35.1) (0.7) (0.6)
4-6 y 432 178 1 4
(70.2) (29.0) (0.2) (0.6)
Total 5048 2836 315 346
Note: Cumulative infection rate % = (total number of age group - both neigative nu
Recent infection rate % = overall IgM+ number of the age/(total number of the ageA clinical study of HCMV reporting 186 hospital cases
from 2003 to 2007 showed that the onset age of HCMV
infection is usually within the first year [7], more in males
than in females (1.9:1). From our survey, new HCMV
infections were concentrated in infants <6 months old,
which is consistent with previous reports.
Our data showed that the total infection rate was signifi-
cantly different between age groups (except for 15–28
days) and 6 months seemed to be the threshold. Ages
under 6 months patients due to the impact of mother
transmitted IgG antibody and gradually increased recent
infection rate, the cumulative infection rate was the high-
est until 6 months. Nevertheless, after 6 months a
decreased trend was seen. The reason might be that the
IgG titers decrease gradually with increasing age.
In addition, the statistical analysis showed that both
the overall distribution and active HCMV infection did
not different by gender in children in Weifang (p >0.05).
It is known that HCMV can be transmitted to the new-
born via the birth canal, breast milk or other sources. In
preterm infants, who are easily infected by HCMV, the
acquired infection ranges from 12–22%, depending on
the gestational age and the breastfeeding duration and
frequency as well as other factors [8]. Thus, although
breast milk is recognized to be the ideal feeding method
for newborns, it can transmit HCMV to the offspring of
HCMV-seropositive mothers. A seroepidemiologic study
in Taiwan indicated that the duration of breastfeeding is
a significant risk factor for HCMV seropositivity. Chil-
dren given HCMV-seropositive breast milk for >24
months are 2.43 times more likely to be infected than
those who are breast fed for ≤24 months (p = 0.0001) [9].ups




16 1502 37.5 1.7
(1) (100)
9 572 32.9 2.3
(1.5) (100)
401 1775 44.7 28.9
(22.6) (100)
160 705 55.3 33.7
(22.7) (100)
52 1864 49.3 5.2
(2.8) (100)
11 819 36.4 2.1
(1.3) (100)
5 615 29.8 1.1
(0.8) (100)
661 7852
mber)/total number × 100.
- IgG+ number) × 100.
Figure 1 Total and recent infection rates in different
age groups.
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breast milk in preterm infants [10,11]. While these proce-
dures might not completely eliminate HCMV, they are less
harmful to the immunological factors contained in breast
milk [12,13].
Seroepidemiological studies also showed that in devel-
oped countries, the HCMV antibody-positive rates in the
high-level socio-economic population is 40-60% while in
the low-level population the rate is >80% [14]. According
to one analysis, the HCMV infection ratios in low-,
medium- and high-income families are 3.5:2.1:1.5 [15].
In our survey, 57.9% of the HCMV-IgM-positive hospi-
talized children were from rural areas and 42.1% from
urban areas, suggesting economic conditions can greatly
affect HCMV infection.
It should be noted that the screening of patients for
HCMV infection is generally performed using either
competitive or indirect ELISAs which detect both IgG
and IgM antibodies. A major disadvantage of HCMV
IgG/IgM antibody detection is the relatively high fre-
quency of false-positives which may be observed in the
absence of specific IgG antibody [16]. False-positive
reactions occur in various conditions unrelated to active
HCMV infection, including polyclonal antibody produc-
tion during infections with other herpes viruses [17],
Epstein-Barr virus, and autoimmune disease [18-20]. In
this study, we excluded other possible infections. Limita-
tions of this survey are that all patients needed to be
screened for the presence of CMV-DNA, especially late
gene transcripts in their blood or urine samples by using
nested-PCR [21]. Despite its preliminary character, this
study clearly indicates that recent HCMV infection is
centered on the first 6 months of life with the evidence
from a large population sample; and the details of
breast milk from HCMV IgM-positive mothers as a
source of infection in children <6 years old remain to
be clarified.Conclusions
In summary, a sero-epidemiology survey was conducted
in Weifang, China. The overall infection rate is 42.5%.
Understanding HCMV prevalence in this eastern city
provides valuable information regarding the epidemi-




Between January 15, 2009 and January 15, 2012, 7852
serum samples were obtained from patients in the Ma-
ternity and Child Health Hospital of Weifang. The par-
ents of all subjects gave written informed consent to the
study protocol, which was approved by the Ethics Com-
mittee of Weifang Medical University (reference number,
wfmu2009005). After excluding those infected with
Toxoplasma gondii, rubella virus, Herpes simplex virus-1,
hepatitis virus or syphilis, the participants were divided
into 7 sub-groups based on age: 1–14 days, 15–28 days,
29 days–3 months, 4–6 months, 7–12 months, 1–3 years
and 4–6 years. Data were recorded as follows: negative for
both CMV-IgG and IgM, positive for HCMV-IgG alone,
positive for IgM alone, positive for both IgG and IgM, and
overall positive for IgM.
Serology and statistics
HCMV serology was performed in the Central Clinical
Laboratory, the Maternity and Child Health Hospital of
Weifang, from January 2009 to January 2012. The pres-
ence of HCMV-specific IgM and IgG antibodies was
assayed using ELISA (Quida, USA), according to the
manufacturer’s instructions. The plate washer (Stat Fax
2600) and microplate reader (Stat Fax 2100) were from
Awareness Technology, Inc., (USA). The sample-to-
cutoff rate (S/CO) was calculated to provide the numeric
value of the test. An S/CO value >1 is considered as
positive, according to the manufacturer. All information
was entered into Excel to create a database and SPSS
13.0 was used for the χ2 test; p <0.05 was considered sta-
tistically significant.
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